Overcoming Immunogenicity in AAV Gene Therapies

Time: 10:00 am
day: Conference Day One - AM


  • The importance of AAV antibody testing in overcoming immunogenicity challenges, ensuring treatment safety, and efficacy
  • Best practices for assay and companion diagnostic development, emphasizing early development, assay format selection, and regulatory expertise
  • Quest Diagnostics' pioneering approach to AAV antibody testing: from assay development and validation to supporting strategic immunomodulation